251 related articles for article (PubMed ID: 1873592)
81. HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse.
Martelli MF; Di Ianni M; Ruggeri L; Falzetti F; Carotti A; Terenzi A; Pierini A; Massei MS; Amico L; Urbani E; Del Papa B; Zei T; Iacucci Ostini R; Cecchini D; Tognellini R; Reisner Y; Aversa F; Falini B; Velardi A
Blood; 2014 Jul; 124(4):638-44. PubMed ID: 24923299
[TBL] [Abstract][Full Text] [Related]
82. Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia.
Deeg HJ; Storb R; Thomas ED; Flournoy N; Kennedy MS; Banaji M; Appelbaum FR; Bensinger WI; Buckner CD; Clift RA
Blood; 1985 Jun; 65(6):1325-34. PubMed ID: 3888312
[TBL] [Abstract][Full Text] [Related]
83. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.
Clift RA; Buckner CD; Appelbaum FR; Bearman SI; Petersen FB; Fisher LD; Anasetti C; Beatty P; Bensinger WI; Doney K
Blood; 1990 Nov; 76(9):1867-71. PubMed ID: 2224134
[TBL] [Abstract][Full Text] [Related]
84. Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sierra J; Radich J; Hansen JA; Martin PJ; Petersdorf EW; Bjerke J; Bryant E; Nash RA; Sanders JE; Storb R; Sullivan KM; Appelbaum FR; Anasetti C
Blood; 1997 Aug; 90(4):1410-4. PubMed ID: 9269758
[TBL] [Abstract][Full Text] [Related]
85. Graft-versus-leukemia reactions after bone marrow transplantation.
Horowitz MM; Gale RP; Sondel PM; Goldman JM; Kersey J; Kolb HJ; Rimm AA; Ringdén O; Rozman C; Speck B
Blood; 1990 Feb; 75(3):555-62. PubMed ID: 2297567
[TBL] [Abstract][Full Text] [Related]
86. Management of graft-versus-host disease in paediatric bone marrow transplant recipients.
Zecca M; Locatelli F
Paediatr Drugs; 2000; 2(1):29-55. PubMed ID: 10937457
[TBL] [Abstract][Full Text] [Related]
87. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease.
Weisdorf DJ; Nesbit ME; Ramsay NK; Woods WG; Goldman AI; Kim TH; Hurd DD; McGlave PB; Kersey JH
J Clin Oncol; 1987 Sep; 5(9):1348-55. PubMed ID: 3305794
[TBL] [Abstract][Full Text] [Related]
88. Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation.
Powles R; Singhal S; Treleaven J; Kulkarni S; Horton C; Mehta J
Blood; 1998 May; 91(9):3481-6. PubMed ID: 9558408
[TBL] [Abstract][Full Text] [Related]
89. T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission.
Young JW; Papadopoulos EB; Cunningham I; Castro-Malaspina H; Flomenberg N; Carabasi MH; Gulati SC; Brochstein JA; Heller G; Black P
Blood; 1992 Jun; 79(12):3380-7. PubMed ID: 1596577
[TBL] [Abstract][Full Text] [Related]
90. Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.
Clift RA; Buckner CD; Appelbaum FR; Schoch G; Petersen FB; Bensinger WI; Sanders J; Sullivan KM; Storb R; Singer J
J Clin Oncol; 1992 Nov; 10(11):1723-9. PubMed ID: 1403055
[TBL] [Abstract][Full Text] [Related]
91. Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission.
Bensinger W; Petersen FB; Banaji M; Buckner CD; Clift R; Slichter SJ; Storb R; Thomas ED
Bone Marrow Transplant; 1989 Jul; 4(4):409-14. PubMed ID: 2673461
[TBL] [Abstract][Full Text] [Related]
92. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.
Sullivan KM; Weiden PL; Storb R; Witherspoon RP; Fefer A; Fisher L; Buckner CD; Anasetti C; Appelbaum FR; Badger C
Blood; 1989 May; 73(6):1720-8. PubMed ID: 2653460
[TBL] [Abstract][Full Text] [Related]
93. Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.
Storb R; Deeg HJ; Fisher L; Appelbaum F; Buckner CD; Bensinger W; Clift R; Doney K; Irle C; McGuffin R
Blood; 1988 Feb; 71(2):293-8. PubMed ID: 3276360
[TBL] [Abstract][Full Text] [Related]
94. Factors affecting survival in allogeneic bone marrow transplantation.
Vogler WR; Winton EF; Reynolds RC; Heffner LT; Gordon DS
Am J Med Sci; 1989 May; 297(5):300-8. PubMed ID: 2655445
[TBL] [Abstract][Full Text] [Related]
95. Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine.
Irle C; Deeg HJ; Buckner CD; Kennedy M; Clift R; Storb R; Appelbaum FR; Beatty P; Bensinger W; Doney K
Leuk Res; 1985; 9(10):1255-61. PubMed ID: 3906282
[TBL] [Abstract][Full Text] [Related]
96. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation.
Weisdorf D; Hakke R; Blazar B; Miller W; McGlave P; Ramsay N; Kersey J; Filipovich A
Transplantation; 1991 Jun; 51(6):1197-203. PubMed ID: 2048196
[TBL] [Abstract][Full Text] [Related]
97. Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease.
deGast GC; Beatty PG; Amos D; Mickelson EM; Sullivan KM; Anderson JE; Giblett ER; Appelbaum F; Storb R; Deeg HJ
Bone Marrow Transplant; 1991 Apr; 7(4):293-5. PubMed ID: 2070135
[TBL] [Abstract][Full Text] [Related]
98. Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation.
Sullivan KM; Deeg HJ; Sanders J; Klosterman A; Amos D; Shulman H; Sale G; Martin P; Witherspoon R; Appelbaum F
Blood; 1986 Apr; 67(4):1172-5. PubMed ID: 3513869
[TBL] [Abstract][Full Text] [Related]
99. Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantation.
Kamoshita S; Murata M; Koyama D; Julamanee J; Okuno S; Takagi E; Miyao K; Goto T; Ozawa Y; Miyamura K; Terakura S; Nishida T; Kiyoi H
Int J Hematol; 2020 Jan; 111(1):112-119. PubMed ID: 31559562
[TBL] [Abstract][Full Text] [Related]
100. Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation.
Yee GC; Self SG; McGuire TR; Carlin J; Sanders JE; Deeg HJ
N Engl J Med; 1988 Jul; 319(2):65-70. PubMed ID: 3288872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
